- Companies
- Zhangshang Tangyi
Zhangshang Tangyi Funding, Investors & Competitors
Zhangshang Tangyi has raised $275M across 4 funding rounds, most recently a $144M Series D in January 2020.
Last Zhangshang Tangyi funding round
$144M
Series D · Jan 2020
Cumulative funding Zhangshang Tangyi raised
$275M
across 4 funding rounds
Key investors in Zhangshang Tangyi
IDG Capital
LB Investment
Ping An Ventures
Matrix Partners China
SIG China (SIG Asia Investments)
Samsung Ventures
CICC
CMB International Capital Corporation
Zhangshang Tangyi Overview
About Zhangshang Tangyi
Zhangshang Tangyi is a health management platform in China focused on diabetes care. Hangzhou-based and founded in 2014, it allows patients to upload glucose readings via apps, receiving doctor guidance. The platform connects 100,000 users with 5,000 physicians across Zhejiang province.
Founded
2014
HQ
Website
Status
Privately held
Customer focus
B2B & B2C
Revenue model
Subscription
Zhangshang Tangyi Funding History
Zhangshang Tangyi has raised a total of $275M across 4 funding rounds.
Zhangshang Tangyi's first fundraising round was a $15M Series A in October 2015. The most recent completed round was a $144M Series D in January 2020.
Zhangshang Tangyi funding rounds
| Date | Stage | Investors | Raised | Deal Summary |
|---|---|---|---|---|
| Jan 2020 | Series D | CMB International Capital Corporation (lead); SIG China (SIG Asia Investments) (lead); Tasly; CLP Data Services; LB Investment; Oriental Patron; Bojiang Capital | $144M | Zhangshang Tangyi is a health management platform focused on diabetes, founded in 2014 and based in Hangzhou, Zhejiang. It enables patients to upload health data via a mobile app and receive treatment guidance from doctors. |
| Jan 2019 | Series C | CICC (lead); IDG Capital; Meinian Onehealth; Samsung Ventures; LB Investment; Tasly Pharmaceutical; China Capital Investment Group; Ping An Ventures | $100M | Zhangshang Tangyi is a health management platform focused on diabetes management, enabling patients to upload health data for monitoring and care. On July 1, 2019, it raised $100 million in a funding round led by CICC, with participation from China Capital Investment Group, Health 100, IDG Capital, LB Investment, Ping An Ventures, Samsung Ventures, and Tasly Pharmaceutical, at a post-money valuation of $130.79 million. This deal was highlighted in the InsurTech sector as part of Q1 2019's record activity, including high volumes of Series B and C rounds. |
| Mar 2018 | Series B | Tianyi Group (lead) | $16M | - |
| Oct 2015 | Series A | IDG Capital (lead); Matrix Partners China; Ping An Ventures | $15M | - |
Who has invested in Zhangshang Tangyi?
16 investors have backed Zhangshang Tangyi across its funding rounds, including IDG Capital, LB Investment, Ping An Ventures, Matrix Partners China, SIG China (SIG Asia Investments) and Samsung Ventures.
Lead investors include CMB International Capital Corporation, SIG China (SIG Asia Investments), CICC, Tianyi Group and IDG Capital.
Zhangshang Tangyi Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
| 2 | Lead | Oct 2015 | ||
| 2 | Participant | Jan 2019 | ||
| 2 | Participant | Oct 2015 | ||
| 1 | Participant | Oct 2015 | ||
| 1 | Participant | Jan 2020 | ||
| 1 | Participant | Jan 2020 | ||
| 1 | Participant | Jan 2019 | ||
| 1 | Lead | Mar 2018 | ||
| 1 | Participant | Jan 2019 | ||
| 1 | Lead | Jan 2019 | ||
| 1 | Participant | Jan 2019 | ||
| 1 | Participant | Jan 2020 | ||
| 1 | Lead | Jan 2020 | ||
This data is available for Pro users. Sign up to see all 16 Zhangshang Tangyi investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialZhangshang Tangyi Competitors
Zhangshang Tangyi competitors include listed companies like IQVIA, Veeva, IDEXX Laboratories and Roper Technologies, and private ones like Commure and Doctolib.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Publicly listed | $16B | $3.4B | $44B | 3.4x | ||
| Publicly listed | $3.2B | $965M | $43B | 10.2x | ||
| Publicly listed | $4.3B | $1.5B | $40B | 8.9x | ||
| Publicly listed | $7.9B | $3.2B | $37B | 5.7x | ||
| Private | $200M | - | $7B | 35.0x | ||
| Private | $400M | - | $6.4B | 16.0x |
Zhangshang Tangyi Public Comps
Zhangshang Tangyi is still privately-owned, but its public comps include Garmin, IQVIA, Veeva, IDEXX Laboratories, Roper Technologies, GE HealthCare, ICON plc, Pro Medicus, United Imaging and Glaukos.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $7.2B | $2.1B | 7.0x | 6.4x | 24.4x | 21.7x | |||
| $16B | $3.4B | 3.6x | 3.4x | 17.2x | 14.8x | |||
| $3.2B | $965M | 11.1x | 10.2x | 36.9x | 22.4x | |||
| $4.3B | $1.5B | 9.5x | 8.9x | 27.1x | 24.9x | |||
| $7.9B | $3.2B | 6.1x | 5.7x | 15.2x | 14.6x | |||
| $21B | $3.7B | 1.8x | 1.8x | 10.1x | 10.0x | |||
| $8.3B | $816M | 1.9x | 1.9x | 19.2x | 11.3x | |||
| $186M | $147M | 66.6x | 62.7x | 84.4x | 77.6x | |||
This data is available for Pro users. Sign up to see all Zhangshang Tangyi competitors and their valuation data. Start Free Trial | ||||||||
Common questions about Zhangshang Tangyi
| When was Zhangshang Tangyi founded? | Zhangshang Tangyi was founded in 2014. |
| Where is Zhangshang Tangyi headquartered? | Zhangshang Tangyi is headquartered in Hangzhou, China. |
| Is Zhangshang Tangyi publicly listed? | No, Zhangshang Tangyi is a private, VC-backed company. |
| How much funding has Zhangshang Tangyi raised? | Zhangshang Tangyi has raised $275M across 4 funding rounds. |
| What was Zhangshang Tangyi's last funding round? | Zhangshang Tangyi's last funding round was a $144M Series D in January 2020, led by CMB International Capital Corporation and SIG China (SIG Asia Investments). |
| Who are Zhangshang Tangyi's investors? | Zhangshang Tangyi's investors include IDG Capital, LB Investment, Ping An Ventures, Matrix Partners China, Tasly, CLP Data Services, Meinian Onehealth, Tianyi Group, Samsung Ventures, CICC and 6 others. |
| Which companies are comparable to Zhangshang Tangyi? | Companies comparable to Zhangshang Tangyi include IQVIA, Veeva, IDEXX Laboratories, Roper Technologies, Commure and Doctolib. |
See companies similar to Zhangshang Tangyi
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




